Clinical-stage biopharmaceutical company Affinivax has secured $226m in Series C financing to advance the development of new vaccines with its multiple antigen presenting system (MAPS) platform.
German pharmaceutical and life sciences company Bayer has entered into a collaboration and services agreement with biopharmaceutical firm CureVac on Covid-19 vaccine called CVnCoV.
Xencor and The University of Texas MD Anderson Cancer Center announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.
Fujifilm is set to invest about $2bn to build a new large-scale cell culture production site for biopharmaceuticals in the US.
Angelini Pharma has agreed to acquire Swiss biopharmaceutical company Arvelle Therapeutics in a deal valued up to $960m.
India's Central Drugs Standard Control Organisation (CDSCO) has given the restricted emergency use approval for Covid-19 vaccines of Serum Institute of India and Bharat Biotech.
Biotechnology company Moderna is negotiating with the South Korean government to potentially provide 40 million or more doses of its vaccine against Covid-19.
Aurobindo Pharma has signed an exclusive license agreement with US-based COVAXX to develop the latter’s UB-612 multitope peptide-based vaccine to fight Covid-19.
Hyundai Bioscience announced that CNPharm, its major shareholding bio tech company, has succeeded in developing 'Poly-COV01,' an injection drug for the potential treatment of patients with severe cases of Covid-19.
Pharmaceutical company Servier has agreed to acquire oncology business from Agios Pharmaceuticals for up to $2bn.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.